JAC Named as Preferred Bidder for Hospital Electronic Prescribing and Medicines Administration (HEPMA) Contract in Scotland
JAC, one of the world’s leading specialist vendors of medicines management software, has been named as one of just two firms to be awarded ‘preferred bidder’ status for a Hospital Electronic Prescribing and Medicines Administration (HEPMA) software contract by NHS Scotland.
22 August 2016 – JAC is pleased to announce that it has been accredited by NHS Scotland to deliver its Hospital Electronic Prescribing and Administration (HEPMA) to Scottish NHS Boards in a framework contract worth £15million. This contract, which is expected to be signed by the end of September, is indicative of Scotland’s commitment to digitise its health services.
JAC’s HEPMA system is an integral component of its end-to-end medicines management platform which includes the requisition, supply and administration of prescribed drugs, along with clinical decision support.
JAC’s HEPMA solution has already been deployed to great effect at four NHS Boards, helping them achieve their Scottish NHS mandated objectives for ehealth. In addition several other Scottish NHS Boards manage their pharmacy services with JAC.
“JAC are delighted to have passed the evaluation and been given preferred status on the HEPMA Framework,” says Robert Tysall-Blay, Chief Executive of JAC. “The funding and focus on hospital e-prescribing as part of the Scottish e-Health Strategy 2014-2017 will certainly help delivery of one of the central aims of the strategy, which is ‘to improve the safety of people taking medicines and their effective use’.”
“We look forward to building on the work already undertaken by the Health Boards in Scotland who are currently using HEPMA from JAC and by helping other Health Boards to align their medicines management strategies with the vision laid down in NHS Scotland’s eHealth Applications strategy.”
Tel: +44 (0) 1268 416348
JAC is a leading specialist supplier of medicines management software to the British NHS and to key sites in the Republic of Ireland and South Africa. With over 30 years’ experience within medicines management, JAC’s UK user-base now accounts for around half of all NHS trusts in England as well as sites in Scotland, Wales and Northern Ireland. JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated medicines management platform. In addition JAC supplies specialist chemotherapy management solutions to NHS sites in England and the South-Eastern Norway Regional Health Authority. JAC is part of the Mediware group of companies.
Mediware Information Systems Inc. (www.mediware.com) delivers interoperable, best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes and decrease costs. Core Mediware solutions include blood management technologies; cell therapy solutions; medication management solutions; and business intelligence-based performance management solutions.